26645EGP
- Active ingredient
- regorafenib
- Strength
- 40mg
- Form
- tablet
- Manufacturer
- bayer healthcare
- Route
- oral.solid
Uses
Kinase inhibitor used for previously treated metastatic colorectal cancer, GIST, and hepatocellular carcinoma.
Do not use if
No absolute contraindications listed; avoid use in severe hypersensitivity.
Side effects
Hepatotoxicity, fatigue, hypertension, diarrhea, hemorrhage, and skin toxicity may occur.
Warnings
Monitor liver function before and during treatment.
How it works
Multikinase inhibitor targeting pathways involved in tumor growth and angiogenesis.
Storage
Store at room temperature in original packaging.
